Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2694094rdf:typepubmed:Citationlld:pubmed
pubmed-article:2694094lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:2694094lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:2694094lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2694094lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2694094lifeskim:mentionsumls-concept:C0812201lld:lifeskim
pubmed-article:2694094lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2694094lifeskim:mentionsumls-concept:C0033713lld:lifeskim
pubmed-article:2694094lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:2694094lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:2694094pubmed:issue3lld:pubmed
pubmed-article:2694094pubmed:dateCreated1990-3-15lld:pubmed
pubmed-article:2694094pubmed:abstractTextc-ets-1 and c-ets-2 are 2 proto-oncogenes known to be possibly involved in some human myelomonocytic leukemias. However, very few studies concern c-ets-1 and c-ets-2 RNA expression in human hematologic malignancies. We have studied 18 leukemic patients, and 10 cell lines for their ets RNA contents. c-ets-1 was strongly expressed in 5 and c-ets-2 in 8 of the 18 patients. All the cell lines expressed both c-ets-1 and c-ets-2 RNAs. This expression was highly variable from one patient to another, and from one cell line to another, regardless of the cellular leukemia subtype. The variability of this expression in patients may reflect differences in the proliferative potential of leukemic cells.lld:pubmed
pubmed-article:2694094pubmed:languageenglld:pubmed
pubmed-article:2694094pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:citationSubsetIMlld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2694094pubmed:statusMEDLINElld:pubmed
pubmed-article:2694094pubmed:authorpubmed-author:GisselbrechtS...lld:pubmed
pubmed-article:2694094pubmed:authorpubmed-author:VaretBBlld:pubmed
pubmed-article:2694094pubmed:authorpubmed-author:PicardFFlld:pubmed
pubmed-article:2694094pubmed:authorpubmed-author:DreyfusFFlld:pubmed
pubmed-article:2694094pubmed:authorpubmed-author:FichelsonSSlld:pubmed
pubmed-article:2694094pubmed:authorpubmed-author:TambourinP...lld:pubmed
pubmed-article:2694094pubmed:volume31lld:pubmed
pubmed-article:2694094pubmed:ownerNLMlld:pubmed
pubmed-article:2694094pubmed:authorsCompleteYlld:pubmed
pubmed-article:2694094pubmed:pagination217-21lld:pubmed
pubmed-article:2694094pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:meshHeadingpubmed-meshheading:2694094-...lld:pubmed
pubmed-article:2694094pubmed:year1989lld:pubmed
pubmed-article:2694094pubmed:articleTitleets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines.lld:pubmed
pubmed-article:2694094pubmed:affiliationLaboratoire d'Immunologie et Virologie des Tumeurs, INSERM U152, Hôpital Cochin, Paris, France.lld:pubmed
pubmed-article:2694094pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2694094pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed